RoslinCT, a biotechnology company headquartered in Edinburgh, announced its appointment of Dr. Jessica Carmen as its new chief commercial officer. The company is a contract development and manufacturing organization focused on creating advanced cell and gene therapies for patients across the globe.
Carmen has two decades of experience in business development, licensing and marketing within the cell and gene therapy industry. Most recently, she served as VP of business development at Kincell Bio. While there, she broadened her technical knowledge of how cell-based medicines are manufactured and what tools and services support their commercialization.
In her new role at RoslinCT, Carmen will lead and coordinate all of the company’s commercial activities. Her responsibilities will include marketing RoslinCT’s technical capabilities, driving new business development and supporting customer relationships.
